Mednax to Present at Upcoming Investor Conferences

first_img Previous articleIn Israel and beyond, virus vaccines bring political powerNext articleJuniper Research: Smart Traffic Management to Significantly Reduce Congestion and Emissions; Saving Cities $277 Billion by 2025 Digital AIM Web Support Facebook By Digital AIM Web Support – February 22, 2021 Facebook Pinterest Pinterest WhatsApp Local NewsBusinesscenter_img TAGS  Mednax to Present at Upcoming Investor Conferences WhatsApp FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Feb 22, 2021– Mednax, Inc. (NYSE: MD) today announced that it is scheduled to make presentations at two upcoming investor conferences. The Company will present on Thursday, February 25, 2021 at 2:25 p.m. ET to investors attending Citi’s 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference. Mednax will also present on Monday, March 1, 2021 at 10:00 a.m. ET to investors attending the J.P. Morgan Global High Yield & Leveraged Finance Conference, taking place virtually. The presentations will be broadcast through live audio webcasts. ABOUT MEDNAX Mednax, Inc. is a national medical group comprised of the nation’s leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telehealth programs to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional entities, Mednax provides services through a network of more than 2,300 physicians in 39 states and Puerto Rico. Additional information is available at www.mednax.com. Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to the Company’s objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by the Company’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the Company’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well the Company’s current reports on Form 8-K, filed with the Securities and Exchange Commission, and include the impact of the COVID-19 pandemic on the Company and its financial condition and results of operations; the effects of economic conditions on the Company’s business; the effects of the Affordable Care Act and potential changes thereto or a repeal thereof; the Company’s relationships with government-sponsored or funded healthcare programs, including Medicare and Medicaid, and with managed care organizations and commercial health insurance payors; the Company’s ability to comply with the terms of its debt financing arrangements; the impact of the divestiture of the Company’s anesthesiology and radiology medical groups; the impact of management transitions; the timing and contribution of future acquisitions; the effects of share repurchases; and the effects of the Company’s transformation initiatives, including its reorientation on, and growth strategy for, its pediatrics and obstetrics business. View source version on businesswire.com:https://www.businesswire.com/news/home/20210222005134/en/ CONTACT: Charles Lynch Senior Vice President, Finance and Strategy 954-384-0175 ext. 5692 charles—[email protected] KEYWORD: UNITED STATES NORTH AMERICA FLORIDA INDUSTRY KEYWORD: NURSING HEALTH HOSPITALS PRACTICE MANAGEMENT MANAGED CARE GENERAL HEALTH SOURCE: Mednax, Inc. Copyright Business Wire 2021. PUB: 02/22/2021 06:45 AM/DISC: 02/22/2021 06:45 AM http://www.businesswire.com/news/home/20210222005134/enCopyright Business Wire 2021. Twitter Twitterlast_img read more


Ministry converts Wisma Atlet Kemayoran into emergency COVID-19 hospital

first_imgThe Public Works and Public Housing Ministry is preparing to turn Wisma Atlet Kemayoran, a former athletes village in Central Jakarta, into an emergency hospital to treat people with COVID-19, according to an official.Wisma Atlet was used in the 2018 Asian Games, which was cohosted by Jakarta and Palembang, South Sumatra.  The sixth and seventh towers, each also providing 650 residential units with a capacity of 1,750 people, will house on-duty health workers and the COVID-19 Task Force, respectively.”We are seeking to complete the COVID-19 Emergency Hospital in the next four days,” the ministry’s housing procurement director general, Khalawi Abdul Hamid, said in a statement released on Thursday. “It’s expected to start operating on Monday.”COVID-19 was first detected in December 2019 in Wuhan, China, and has since spread to the rest of the world, including Indonesia, with confirmed cases mainly found in Jakarta. Out of the 309 confirmed cases nationwide, 210 are in the capital, according to the Health Ministry’s disease control and prevention director general, Achmad “Yuri” Yurianto.State-owned diversified manufacturer PT Rajawali Nusantara Indonesia, which also oversees imports of 500,000 rapid testing kits for COVID-19 from China, will be in charge of operations and maintenance of the Wisma Atlet emergency hospital.”[The use of] Wisma Atlet is still under further discussion,” Yuri, who also acts as the government’s spokesperson for COVID-19, told The Jakarta Post via text message on Thursday. (dfr) Four of its 10 towers will be converted to treat COVID-19 patients. Meanwhile, one tower, which consists of 650 residential units that can house 1,750 people, has been designated as an emergency hospital for hospice care. Another tower comprising 886 units and with a capacity of 2,458 people will support the emergency hospital, with the first floor allocated for emergency rooms, the second floor for intensive care units and the third floor for recovery rooms.The fourth to 24th floors are will used as regular hospice rooms. center_img Topics :last_img read more